Mingzhi Zhang

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Diffuse Large B Cell Lymphoma

Acute Lymphoblastic Leukemia

Top Venues

OncoTargets and therapy

Cancer management and research

Journal of cellular and molecular medicine

Journal of neuro-oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhuangzhuang Shi, Zhaoming Li, Mingzhi Zhang
Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies. Journal of translational medicine 22 (1) (2024)
Mei Mei, Yingjun Wang, Wenting Song, Zhaoming Li, Qilong Wang, Jiayin Li, Mingzhi Zhang
CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3. Cancer cell international 21 (1) (2021)
Mei Mei, Yingjun Wang, Wenting Song, Mingzhi Zhang
Primary Causes of Death in Patients with Non-Hodgkin's Lymphoma: A Retrospective Cohort Study. Cancer management and research 12 (2020)
Mingzhi Zhang, Lei Zhang, Ling Li, Xin Li, Jiaqin Yan, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Xudong Zhang, Zhaoming Li, Jingjing Wu, Hui Yu, Yu Chang, Zhiyuan Zhou, Feifei Nan, Xiaolong Wu, Li Tian, Mingzhi Zhang
Effective Treatment with PD-1 Antibody, Chidamide, Etoposide, and Thalidomide (PCET) for Relapsed/Refractory Natural Killer/T-Cell Lymphoma: A Report of Three Cases. OncoTargets and therapy 13 (2020)
Xinran Ma, Ling Li, Lei Zhang, Xiaorui Fu, Xin Li, Xinhua Wang, Jingjing Wu, Zhenchang Sun, Xudong Zhang, Xiaoyan Feng, Yu Chang, Zhiyuan Zhou, Feifei Nan, Jieming Zhang, Zhaoming Li, Mingzhi Zhang
Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study. Drug design, development and therapy 14 (2020)
Mei Mei, Yingjun Wang, Mingzhi Zhang
Causes of mortality in cases with extra nodal natural killer/T-cell lymphoma, nasal type: A cohort study. PloS one 14 (4) (2019)
Jingjing Wu, Lingling Duan, Lei Zhang, Zhenchang Sun, Xiaorui Fu, Xin Li, Ling Li, Xinhua Wang, Xudong Zhang, Zhaoming Li, Hui Yu, Yu Chang, Feifei Nan, Jiaqin Yan, Li Tian, Xiaoli Wang, Mingzhi Zhang
Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial. Journal of neuro-oncology 140 (2) (2018)
Xuan Lan, Zhaoming Li, Mingzhi Zhang
Analysis of clinical characteristics and prognosis factors of 71 cases with HIV-negative Castleman's disease: hypoproteinemia is an unfavorable prognostic factor which should be treated appropriately. Journal of cancer research and clinical oncology 144 (7) (2018)
Weili Xue, Weiming Li, Yufeng Shang, Yanjie Zhang, Xuan Lan, Guannan Wang, Zhaoming Li, Xudong Zhang, Yue Song, Baopeng Wu, Meng Dong, Xinhua Wang, Mingzhi Zhang
One method to establish Epstein-Barr virus-associated NK/T cell lymphoma mouse models. Journal of cellular and molecular medicine 23 (2) (2018)